Literature DB >> 8338004

Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes.

M Mosseri1, A N Bartlett-Pandite, K Wenc, J M Isner, R Weinstein.   

Abstract

Interactions between erythrocytes and vascular endothelium have been implicated in the pathogenesis of vaso-occlusion in sickle cell anemia. Sickle erythrocytes adhere to endothelial cells and facilitate trapping of rigid sickle cells in microvessels. Compensatory dilation of precapillary arterioles may mitigate the occlusion. The endothelium regulates vasoreactivity by elaborating endothelium-derived relaxing factor (EDRF), a small molecule that passes freely into vascular smooth muscle where it initiates vasorelaxation by activating soluble guanylate cyclase in the smooth muscle cell cytoplasm. Endothelial release of EDRF can be stimulated by agonists such as acetylcholine. It is highly sensitive to decomposition by superoxide anions and is rapidly bound and inactivated by oxyhemoglobin in solution. The purpose of this study was to determine whether sickle cell interaction with endothelium disrupts this mechanism of endothelial regulation of vasomotor tone. Transverse strips of rabbit aorta, mounted isometrically in organ baths, were contracted with norepinephrine, and relaxation responses to acetylcholine or other agonists were determined. Responses were measured under control conditions and again in the presence of oxyhemoglobin A or S, or erythrocytes or ghosts from normal control subjects or patients with homozygous sickle cell anemia. Sickle erythrocytes inhibited vasorelaxation to acetylcholine by 83%. Approximately half of the inhibition was attributable to a small amount of oxyhemoglobin S that was leaked into the buffer from the erythrocytes. Consistent with this, sickle erythrocyte ghosts inhibited vasorelaxation to acetylcholine by up to 45%. Ghosts from normal erythrocytes did not inhibit vasorelaxation to acetylcholine, and the inhibition seen with normal erythrocytes was entirely attributable to leakage of oxyhemoglobin A into the bath buffer.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338004     DOI: 10.1016/0002-8703(93)91049-k

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy.

Authors:  Ashlee N Higdon; Gloria A Benavides; Balu K Chacko; Xiaosen Ouyang; Michelle S Johnson; Aimee Landar; Jianhua Zhang; Victor M Darley-Usmar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-13       Impact factor: 4.733

2.  Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice.

Authors:  Jochen Steppan; Huong T Tran; Valeriani R Bead; Young Jun Oh; Gautam Sikka; Trinity J Bivalacqua; Arthur L Burnett; Dan E Berkowitz; Lakshmi Santhanam
Journal:  Anesth Analg       Date:  2016-09       Impact factor: 5.108

3.  Intravascular flow decreases erythrocyte consumption of nitric oxide.

Authors:  J C Liao; T W Hein; M W Vaughn; K T Huang; L Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

4.  Association between Endothelial Dysfunction, Biomarkers of Renal Function, and Disease Severity in Sickle Cell Disease.

Authors:  Oluwagbemiga Oluwole Ayoola; Rahman Ayodele Bolarinwa; Chidiogo Chukwunweike Onwuka; Bukunmi Michael Idowu; Adeniyi Sunday Aderibigbe
Journal:  Kidney360       Date:  2020-01-31

5.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

6.  Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture.

Authors:  M Phelan; S P Perrine; M Brauer; D V Faller
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 7.  Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease.

Authors:  E S Klings; H W Farber
Journal:  Respir Res       Date:  2001-07-13

8.  Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.

Authors:  M Al Huneini; S Alkindi; V Panjwani; K Al Falahi; B Al Balushi; D Gravell; C H Ho; R Krishnamoorthy; A V Pathare
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-04-20       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.